Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 22956508)

1.

Methods for cancer epigenome analysis.

Nagarajan RP, Fouse SD, Bell RJ, Costello JF.

Adv Exp Med Biol. 2013;754:313-38. doi: 10.1007/978-1-4419-9967-2_15. Review.

2.

Studying the epigenome using next generation sequencing.

Ku CS, Naidoo N, Wu M, Soong R.

J Med Genet. 2011 Nov;48(11):721-30. doi: 10.1136/jmedgenet-2011-100242. Epub 2011 Aug 8. Review.

PMID:
21825079
3.
4.

Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.

Wang Z, Yue Y, Han P, Sa R, Ren X, Wang J, Bai H, Yu H.

Cytotherapy. 2013 Sep;15(9):1164-73. doi: 10.1016/j.jcyt.2013.05.001. Epub 2013 Jun 22.

PMID:
23800731
5.

Epigenetic epidemiology for cancer risk: harnessing germline epigenetic variation.

Brennan K, Flanagan JM.

Methods Mol Biol. 2012;863:439-65. doi: 10.1007/978-1-61779-612-8_27. Review.

PMID:
22359310
6.
7.

The cancer epigenome--components and functional correlates.

Ting AH, McGarvey KM, Baylin SB.

Genes Dev. 2006 Dec 1;20(23):3215-31. Review.

8.

Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application.

Nogueira da Costa A, Herceg Z.

Mol Oncol. 2012 Dec;6(6):704-15. doi: 10.1016/j.molonc.2012.07.005. Epub 2012 Aug 16. Review.

9.

Gene methylation in gastric cancer.

Qu Y, Dang S, Hou P.

Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Review.

10.

Histone modifications and chromatin organization in prostate cancer.

Chen Z, Wang L, Wang Q, Li W.

Epigenomics. 2010 Aug;2(4):551-60. doi: 10.2217/epi.10.31. Review.

11.

Next-generation technologies and data analytical approaches for epigenomics.

Mensaert K, Denil S, Trooskens G, Van Criekinge W, Thas O, De Meyer T.

Environ Mol Mutagen. 2014 Apr;55(3):155-70. doi: 10.1002/em.21841. Epub 2013 Dec 10. Review.

PMID:
24327356
12.

Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets.

Malzkorn B, Wolter M, Riemenschneider MJ, Reifenberger G.

Brain Pathol. 2011 Nov;21(6):619-32. doi: 10.1111/j.1750-3639.2011.00536.x. Review.

PMID:
21939466
13.

Integrated epigenome profiling of repressive histone modifications, DNA methylation and gene expression in normal and malignant urothelial cells.

Dudziec E, Gogol-Döring A, Cookson V, Chen W, Catto J.

PLoS One. 2012;7(3):e32750. doi: 10.1371/journal.pone.0032750. Epub 2012 Mar 7.

14.

A decade of exploring the cancer epigenome - biological and translational implications.

Baylin SB, Jones PA.

Nat Rev Cancer. 2011 Sep 23;11(10):726-34. doi: 10.1038/nrc3130. Review.

15.

Techniques to study epigenetic control and the epigenome in parasites.

Nardelli SC, Ting LM, Kim K.

Methods Mol Biol. 2015;1201:177-91. doi: 10.1007/978-1-4939-1438-8_10.

PMID:
25388114
16.

Analysis of gene-specific and genome-wide sperm DNA methylation.

Hammoud SS, Cairns BR, Carrell DT.

Methods Mol Biol. 2013;927:451-8. Review.

PMID:
22992936
17.

Histone modifications for human epigenome analysis.

Kimura H.

J Hum Genet. 2013 Jul;58(7):439-45. doi: 10.1038/jhg.2013.66. Epub 2013 Jun 6. Review.

PMID:
23739122
18.

Discovery and development of DNA methylation-based biomarkers for lung cancer.

Walter K, Holcomb T, Januario T, Yauch RL, Du P, Bourgon R, Seshagiri S, Amler LC, Hampton GM, S Shames D.

Epigenomics. 2014 Feb;6(1):59-72. doi: 10.2217/epi.13.81.

PMID:
24579947
19.

Genome-wide epigenetic analysis of human pluripotent stem cells by ChIP and ChIP-Seq.

Hitchler MJ, Rice JC.

Methods Mol Biol. 2011;767:253-67. doi: 10.1007/978-1-61779-201-4_19.

PMID:
21822881
20.

Molecular epigenetics and genetics in neuro-oncology.

Nagarajan RP, Costello JF.

Neurotherapeutics. 2009 Jul;6(3):436-46. doi: 10.1016/j.nurt.2009.04.002. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk